James A. Robinson Jr. - 25 Jul 2023 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
25 Jul 2023
Transactions value $
$0
Form type
4/A - Amendment
Filing time
28 Jul 2023, 18:05:31 UTC
Date Of Original Report
27 Jul 2023
Previous filing
01 Dec 2022
Next filing
08 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Award $0 +20K $0.00 20K 25 Jul 2023 Ordinary Shares 20K $8.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest in equal quarterly installments over 12 months